JPRN-UMIN000038279已完成未知
Phase I/II clinical trial of hypofractionated image-guided proton therapy for prostate cancer - Phase I/II clinical trial of hypofractionated image-guided proton therapy for prostate cancer
agoya City University West Medical Center0 个研究点目标入组 300 人开始时间: 2020年1月6日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 300
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)pathological specimen is not available to confirm the diagnosis 2)previous radiotherapy around the lesion 3)surgery for prostate cancer is performed prior to registration 4)active and uncontrolled infection 5)two or more anticoagulants and antiplatelets 6)bowel disease such as ulcerative colitis or postoperative rectal cancer 7)patients who cannot or refuse gold markers and Space OAR 8)serious complication 9)cases in which the doctor is judged inappropriate for medical or other reasons
研究者
相似试验
已完成
不适用
Phase II trial of hypofractionated intensity modulated radiotherapy in patients with low risk prostate cancerProstate cancerJPRN-UMIN000022570Kitasato university55
已完成
2 期
Phase II clinical trial of hypofractionated radiotherapy using proton beams for prostate cancerProstate cancerJPRN-UMIN000010510Proton Medical Research Center, University of Tsukuba102
招募中
3 期
Phase III trial of hypo-fractionated accelerated intensity modulated radiotherapy with concurrent and maintenance temozolomide in newly diagnosed Glioblastoma (HYART-GBM)CTRI/2020/06/025573AIIMS New Delhi
撤回
2 期
Hypofractionated Radiotherapy With Carboplatin and Paclitaxel in Non-Small Cell Lung CancerNon Small Cell Lung CancerNCT03699033Stephanie Smiddy
进行中（未招募）
2 期
Gateway-studyewly Diagnosed glioblastomaglioblastomaJPRN-jRCTs051180159Kijima Noriyuki65